Clear Labs Launches Clear Dx™ Deeplex® Myc-TB, An Automated Solution for Mycobacterium Species Identification and TB Drug Resistance Mutations
Summary
Clear Labs launched Clear Dx Deeplex Myc-TB, an automated assay for identifying Mycobacterium species and detecting TB drug resistance mutations. The product integrates with the Clear Dx platform and is available for research use only. Clear Labs says the solution speeds up workflows, reduces manual error, and returns next-day results from DNA extracted from clinical specimens. GenoScreen partnered on the launch by contributing the underlying Deeplex Myc-TB assay technology.
Classifications
industries
AgriTech
applications
Data Management
AskAI Classifications
Labels
SaaS
Bioinformatics Software
Laboratory Information Systems
Linked Companies
Clear Labs
$1M to $5M